Phase I study of cemiplimab, a human monoclonal anti-PD-1, in patients with unresectable locally advanced or metastatic cutaneous squamous cell carcinoma (CSCC): Longer follow-up e... von Owonikoko, T.K., Papadopoulos, K.P., Gil-Martin, M., Moreno, V., Salama, A.K., Calvo, E., Safran, H., González-Martín, A., Aljumaily, R., Mahadevan, D., Niu, J., Kal Mohan, K., Li, J., Stankevich, E., Mathias, M., Lowy, I., Fury, M.G., Babiker, H.M.

Volltext

Phase I study of cemiplimab, a human monoclonal anti-PD-1, in patients with unresectable locally advanced or metastatic cutaneous squamous cell carcinoma (CSCC): Longer follow-up e... von Owonikoko, T.K., Papadopoulos, K.P., Johnson, M.L., Gil Martín, M., Moreno, V., Salama, A.K., Calvo, E., Yee, N.S., Safran, H., Aljumaily, R., Mahadevan, D., Niu, J., Kal Mohan, K., Li, J., Stankevich, E., Mathias, M., Lowy, I., Fury, M.G., Babiker, H.M.

Volltext

71PPhase I study of cemiplimab, a human monoclonal anti-PD-1, in patients with unresectable locally advanced or metastatic cutaneous squamous cell carcinoma (CSCC): Longer follow-u... von Owonikoko, T K, Papadopoulos, K P, Johnson, M L, Gil Martín, M, Moreno, V, Salama, A K, Calvo, E, Yee, N S, Safran, H, Aljumaily, R, Mahadevan, D, Niu, J, Kal Mohan, K, Li, J, Stankevich, E, Mathias, M, Lowy, I, Fury, M G, Babiker, H M

Volltext

1292PPhase I study of cemiplimab, a human monoclonal anti-PD-1, in patients with unresectable locally advanced or metastatic cutaneous squamous cell carcinoma (CSCC): Longer follow... von Owonikoko, T K, Papadopoulos, K P, Gil-Martin, M, Moreno, V, Salama, A K, Calvo, E, Safran, H, González-Martín, A, Aljumaily, R, Mahadevan, D, Niu, J, Kal Mohan, K, Li, J, Stankevich, E, Mathias, M, Lowy, I, Fury, M G, Babiker, H M

Volltext

Cemiplimab (REGN2810): A fully human anti-PD-1 monoclonal antibody for patients with unresectable locally advanced or metastatic cutaneous squamous cell carcinoma (CSCC)—Initial sa... von Papadopoulos, Kyriakos P, Owonikoko, Taofeek Kunle, Johnson, Melissa, Brana, Irene, Gil Martin, Marta, Perez, Raymond P., Moreno, Victor, Salama, April K., Calvo, Emiliano, Yee, Nelson S, Safran, Howard, Gonzalez Martin, Antonio, Aljumaily, Raid, Mahadevan, Daruka, Mohan, Kosalai Kal, Li, Jingjin, Stankevich, Elizabeth, Lowy, Israel, Fury, Matthew G., Homsi, Jade

Volltext

REGN2810: A fully human anti-PD-1 monoclonal antibody, for patients with unresectable locally advanced or metastatic cutaneous squamous cell carcinoma (CSCC)—Initial safety and eff... von Papadopoulos, Kyriakos P., Owonikoko, Taofeek Kunle, Johnson, Melissa Lynne, Brana, Irene, Gil-Martin, Marta, Perez, Raymond P., Moreno, Victor, Salama, April K., Calvo, Emiliano, Yee, Nelson S., Safran, Howard, González-Martín, Antonio, Aljumaily, Raid, Mahadevan, Daruka, Mohan, Kosalai Kal, Qin, Rui, Stankevich, Elizabeth, Lowy, Israel, Fury, Matthew G., Homsi, Jade

Volltext